Dendritic cells and vascular endothelial growth factor in colorectal cancer: Correlations with clinicobiological findings

Oncology

Volumn 68, Issue 2-3, 2005, Pages 276-284

  Della Porta, Matteo ^a   Danova, Marco ^b   Rigolin, Gian Matteo ^a   Brugnatelli, Silvia ^b   Rovati, Bianca ^b   Tronconi, Chiara ^b   Fraulini, Chiara ^a   Rossi, Antonella Russo ^a   Riccardi, Alberto ^b   Castoldi, Gianluigi ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Colorectal cancer; Dendritic cells; Vascular endothelial growth factor

Indexed keywords

CD11 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; HLA DR ANTIGEN; MANNOSE RECEPTOR; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; LEUKOCYTE ANTIGEN; VASCULOTROPIN A;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PATIENT; CANCER SURGERY; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME; APOPTOSIS; CANCER STAGING; CASE CONTROL STUDY; COLORECTAL TUMOR; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; APOPTOSIS; CASE-CONTROL STUDIES; CELL COUNT; COLORECTAL NEOPLASMS; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 23844534809     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086784     Document Type: Article

References (37)

1. Hart DNJ: Dendritic cells: Unique leukocyte populations, which control the primary immune response. Blood 1997;90:3245-3287.
2. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998;392:245-252.
3. Robinson SP, Patterson S, English N, Davies D, Knight SC, Reid CDL: Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol 1999;29:2769-2778.
4. Reid SD, Penna G, Adorini L: The control of T cell responses by dendritic cell subsets. Curr Opin Immunol 2000;12:114-121.
5. Grabbe S, Beissert S, Shwarz T, Granstein RD: Dendritic cells as initiators of immune response: A possible strategy for tumor immunotherapy? Immunol Today 1995;16:117-121.
6. Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Kavanaugh D, Carbone DP: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 1996;2:1096-1103.
7. Menetrier-Caux C, Montmain G, Dieu MC, Bain C, Favrot MC, Caux C, Blay JY: Inhibition of the differentiation of dendritic cells from CD 34+ progenitors by tumor cells: Role of intreleukin-6 and macrophage colony-stimulating factor. Blood 1998;92:4778-4791.
8. Folkman J: Angiogenesis in cancer, vascular rheumatoid and other diseases. Nat Med 1995;1:27-31.
9. Carmeliet P: Mechanism of angiogenesis and arteriogenesis. Nat Med 2000;6:389-395.
10. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 1995;18:1029-1039.
11. Gabrilovich D, Ishida T, Oyama T, Ran S, Kravtsov V, Nadaf S, Carbone P: Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affect differentiation of multiple hematopoietic lineages in vivo. Blood 1999;92:4150-4166.
12. Gabrilovich DJ, Corak J, Ciernik IF, Kavanaugh D, Carbone DP: Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res 1997;3:483-490.
13. Lissoni P, Vigore L, Ferranti R, Bukovec R, Meregalli S, Mandala M, Barni S, Tancini G, Fumagalli L, Giani L: Circulating dendritic cells in early and advanced cancer patients: Diminished percent in the metastatic disease. J Biol Regul Homeost Agents 1999;13:216-219.
14. Rigolin GM, Howard J, Buggins A, Sneddon C, Castoldi G, Hirst WJR, Mufti GJ: Phenotypic and functional characteristics of monocyte-derived dendritic cells from patients with myelodysplastic syndromes. Br J Haematol 1999;107:844-850.
15. Lissoni P, Malugani F, Bonfanti A, Bukovec R, Secondino S, Brivio F, Ferrari-Bravo A, Ferrante R, Vigore L, Rovelli F, Mandala M, Viviani S, Fumagalli L, Cardani GS: Abnormally enhanced blood concentration of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1. J Biol Regul Homeost Agents 2001;15:140-144.
16. Rigolin GM, Della Porta M, Bigoni R, Tieghi A, Cuneo A, Castoldi G: Dendritic cells in acute promyelocytic leukemia. Br J Hematol 2001;114:830-833.
17. Almand B, Resser JR, Lindman B, Nadaf S, Clark JI, Kwon ED, Carbone DP, Gabrilovich D: Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res 2000;6:1755-1766.
18. Della Porta M, Rigolin GM, Bugli AM, Bragotti LZ, Bigoni R, Cuneo A, Castoldi G: Differentiation of follicular dendritic sarcoma cells into functional myeloid-dendritic cell-like elements. Eur J Hematol 2003;70:315-318.
19. Huang A, Gilmour JW, Imami N, Amjadi P, Henderson DC, Allen-Mersh TG: Increased serum transforming growth factor beta-1 in human colorectal cancer correlates with reduced circulating dendritic cells and increased colonie Langerhans cell infiltration. Clin Exp Immunol 2003;134:270-278.
20. Ohm JE, Carbone DP: VEGF as a mediator of tumor-associated immunodeficiency. Immunol Res 2001;23:263-272.
21. Astler VB, Coller FA: The prognostic significance of direct extension of carcinoma of the colon and the rectum. Ann Surg 1954;139:846-852.
22. Chau I, Cunningham D: Adjuvant therapy in colon cancer: current status and future directions. Cancer Treat Rev 2002;28:223-236.
23. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macropahge colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179:1109-1118.
24. Ahmed SA, Gogal RM, Walsh JE: A new rapid and simple nonradioactive assay to monitor and determine the proliferation of lymphocytes: An alternative to [3H]thymidine incorporation assay. J Immunol Methods 1994;170:211-224.
25. Ioannides C, Whiteside T: T-cell recognition of human tumors: Implications for molecular immunotherapy of cancer. Clin Immunol Immunopathol 1993;66:91-106.
26. Cella M, Döring C, Samaridis J, Dessing M, Brockhaus M, Lanzavecchia A, Colonna M: A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages and dendritic cells involved in antigen processing. J Exp Med 1997;185:1743-1751.
27. Della Porta M, Rigolin GM, Alessandrino EP, Maiocchi M, Malcovati L, Vanelli L, Baratè C, Rumi E, Ciccone M, Cuneo A, Lazzarino M, Castoldi G: Dendritic cell recovery after allogeneic stem cell transplantation in acute leukemia: Correlations with clinical and transplant characteristics. Eur J Hematol 2004;72:18-25.
28. Ju XS, Hacker C, Scherer B, Redecke V, Berger T, Schuler G, Wagner H, Lipford GB, Zenke M: Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation. Gene 2004;331:159-164.
29. Baggiolini M: Chemokines and leukocyte traffic. Nature 1998;392:565-568.
30. Zou W, Machelon V, Coulomb-L'Hermin A, Borvak J, Nome F, Isaeva T, Wei S, Krzysiek R, Durand-Gasselin I, Gordon A, Pustilnik T, Curiel DT, Galanau GP, Capron F, Emilie D, Curiel TJ: Stromal derived factor 1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med 2001;7:1339-1346.
31. Penna G, Sozzani S, Adorini L: Cutting edge: Selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol 2001;167:1862-1866.
32. Nakayama Y, Sako T, Shibao K, Okazaki K, Rempo N, Onitsuka K, Minagawa N, Akahane K, Nagashima N, Nagata N, Itoh H: Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer. Anti-cancer Res 2002;22:2437-2442.
33. Takahashi A, Kono K, Ichihara F, Sugai H, Fujii H, Matsumoto Y: Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines. Cancer Immunol Immunother 2004;53:543-550.
34. Kiertsher SM, Lupo J, Dubinett SM, Roth MD: Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells. J Immunol 2000;164:1269-1276.
35. Rafii S, Lyden D, Benezra R, Hattori K, Heissig B: Vascular and haematopoietic stem cells: Novel target for anti-angiogenesis therapy? Nat Rev Cancer 2002;2:826-835.
36. Gabrilovich D, Ishida T, Nadaf S, Ohm J, Carbone D: Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function. Clin Cancer Res 1999;5:2963-2970.
37. Nair S, Boczkowski D, Moeller B, Dewhirst M, Vieweg J, Gilboa E: Synergy between tumor immunotherapy and antiangiogenic therapy. Blood 2003;102:964-971.